Administration of Maresin-1 ameliorates the physiopathology of experimental autoimmune encephalomyelitis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Administration of Maresin-1 ameliorates the physiopathology of experimental autoimmune encephalomyelitis ; volume:19 ; number:1 ; day:2 ; month:2 ; year:2022 ; pages:1-18 ; date:12.2022
Journal of neuroinflammation ; 19, Heft 1 (2.2.2022), 1-18, 12.2022
- Urheber
-
Sánchez-Fernández, Alba
Zandee, Stephanie
Mastrogiovanni, Mauricio
Charabati, Marc
Rubbo, Homero
Prat, Alexandre
López-Vales, Rubèn
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12974-022-02386-1
- URN
-
urn:nbn:de:101:1-2022051119280607599201
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sánchez-Fernández, Alba
- Zandee, Stephanie
- Mastrogiovanni, Mauricio
- Charabati, Marc
- Rubbo, Homero
- Prat, Alexandre
- López-Vales, Rubèn
- SpringerLink (Online service)
Ähnliche Objekte (12)
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
ADAMTS13 ameliorates inflammatory responses in experimental autoimmune encephalomyelitis
Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation
Role of eosinophils in experimental autoimmune encephalomyelitis
Claudin-1 induced sealing of blood–brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis
P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis
Neonatal tolerance and experimental autoimmune encephalomyelitis
Neuronal Response to Experimental Autoimmune Encephalomyelitis
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
ADAMTS13 ameliorates inflammatory responses in experimental autoimmune encephalomyelitis
Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation
Role of eosinophils in experimental autoimmune encephalomyelitis
Claudin-1 induced sealing of blood–brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis
P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis
Neonatal tolerance and experimental autoimmune encephalomyelitis
Neuronal Response to Experimental Autoimmune Encephalomyelitis
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
ADAMTS13 ameliorates inflammatory responses in experimental autoimmune encephalomyelitis
Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation
Role of eosinophils in experimental autoimmune encephalomyelitis
Claudin-1 induced sealing of blood–brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis
P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis
Neonatal tolerance and experimental autoimmune encephalomyelitis